NCT01310673View on ClinicalTrials.gov

Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
GoutGout Acute
Interventions
DRUG

Allopurinol

"Allopurinol 300mg po QD for 30 days.~Indomethacin 50mg TID for 10 days. Colchicine 0.6mg po Bid or QD, as tolerated for 90 days."

DRUG

Placebo

"Placebo tablet QD for 10 days, followed by delayed allopurinol 300mg po QD days 11-30.~Indomethacin 50mg TID for 10 days. Colchicine 0.6mg po Bid or QD, as tolerated for 90 days."

Trial Locations (1)

05009

White River Junction VA Medical Center, White River Junction

All Listed Sponsors
lead

White River Junction Veterans Affairs Medical Center

FED

NCT01310673 - Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout | Biotech Hunter | Biotech Hunter